Indian J Pharm Close
 

Figure 3: Comparison of alfuzosin, tamsulosin and silodosin in benign prostatic hyperplasia: Change in quality of life score. The improvement in mean quality of life score from baseline to 2 weeks (visit 1), 4 weeks (visit 2), 8 weeks (visit 3), and 12 weeks (visit 4) with the three study medications

Figure 3: Comparison of alfuzosin, tamsulosin and silodosin in benign prostatic hyperplasia: Change in quality of life score. The improvement in mean quality of life score from baseline to 2 weeks (visit 1), 4 weeks (visit 2), 8 weeks (visit 3), and 12 weeks (visit 4) with the three study medications